CERE — Cerevel Therapeutics Holdings, Inc.
NASDAQ · Healthcare · Biotechnology
Company fundamentals
| Metric | Cached value |
|---|---|
| Price (USD) | 44.96 |
| Market cap (USD) | 8,191,487,500 |
| P/E | -16.83 |
| ROE (%) | -72.44 |
| Net profit margin (%) | 0 |
| Revenue growth (%) | Not available |
| Dividend yield (%) | 0 |
Price last refreshed: .
Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.
About Cerevel Therapeutics Holdings, Inc.
Available company fundamentals for CERE in Biotechnology. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.